116351000: Dihydrocodeine bitartrate (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

177290013 Dihydrocodeine bitartrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

677616017 Dihydrocodeine bitartrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2622601000005119 Dihydrocodeinbitartrat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dihydrocodeinbitartrat	Is a	Product containing dihydrocodeine (medicinal product)	false	Inferred relationship	Some
Dihydrocodeinbitartrat	Is a	Opiate agonist (substance)	false	Inferred relationship	Some
Dihydrocodeinbitartrat	Is a	Opioid receptor agonist	false	Inferred relationship	Some
Dihydrocodeinbitartrat	Is a	Dihydrocodeine (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeinbitartrat	Inferred relationship	Some
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeinbitartrat	Inferred relationship	Some
acetylsalicylsyre + caffein + dihydrocodeinbitartrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeinbitartrat	Inferred relationship	Some
paracetamol + caffein + dihydrocodeinbitartrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeinbitartrat	Inferred relationship	Some
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeinbitartrat	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

SAME AS association reference set (foundation metadata concept)